Start with its own history
At 12.99×, ZBH is 71.5% below its 8-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.
NYSE · ZBHMedical - DevicesUpdated Nov 4, 2026
Zimmer Biomet Holdings, Inc. P/E ratio
Current valuation, historical context, and peer comparisons.
Current P/E ratio
12.99×
71.5% belowthe 8-observation annual average
Share price110.15
÷Earnings per share8.48
Price and EPS in quote currency. Calculation details
Investors are paying 12.99 for every 1 of reported earnings per share.
P/E over time
2016 – 2025
Annual P/ESelected-period average 45.51×
3-year average24.59×3 positive annual observations
5-year average51.09×5 positive annual observations
10-year average45.51×8 positive annual observations
Peer median · TTM22.23×7 peers with positive P/E
Historical P/E ratios
Annual period-end data · 25 observations
| Period end | P/E | Change |
|---|---|---|
| Dec 31, 2025 | 25.26× | +6.4% |
| Dec 31, 2024 | 23.74× | -4.2% |
| Dec 31, 2023 | 24.79× | -78.6% |
| Dec 31, 2022 | 115.91× | +76.2% |
| Dec 31, 2021 | 65.77× | N/M |
| Dec 31, 2020 | N/M | N/M |
| Dec 31, 2019 | 27.10× | N/M |
| Dec 31, 2018 | N/M | N/M |
View all 25 annual observations +
| Period end | P/E | Change |
|---|---|---|
| Dec 31, 2017 | 13.24× | -80.6% |
| Dec 31, 2016 | 68.29× | -82.0% |
| Dec 31, 2015 | 379.65× | +1327.1% |
| Dec 31, 2014 | 26.60× | +28.3% |
| Dec 31, 2013 | 20.74× | +34.5% |
| Dec 31, 2012 | 15.42× | +17.3% |
| Dec 31, 2011 | 13.15× | -27.0% |
| Dec 31, 2010 | 18.00× | +1.8% |
| Dec 31, 2009 | 17.68× | +63.3% |
| Dec 31, 2008 | 10.83× | -46.3% |
| Dec 31, 2007 | 20.15× | -11.8% |
| Dec 31, 2006 | 22.83× | +0.3% |
| Dec 31, 2005 | 22.77× | -36.9% |
| Dec 31, 2004 | 36.06× | -14.4% |
| Dec 31, 2003 | 42.13× | +35.0% |
| Dec 31, 2002 | 31.19× | -21.3% |
| Dec 31, 2001 | 39.63× | N/M |
Change is relative to the preceding observation. N/M values are excluded from averages.
How ZBH compares
Company P/E vs. peer trailing-12-month ratios
| Company | P/E ratio |
|---|---|
 ZBH This stockZimmer Biomet Holdings, Inc. | 12.99× |
 OFIXOrthofix Medical Inc. | N/M |
 SNNSmith & Nephew plc | 21.09× |
 SYKStryker Corporation | 35.94× |
 MDTMedtronic Plc | 25.66× |
 BSXBoston Scientific Corporation | 19.33× |
 GEHCGE HealthCare Technologies Inc. | 22.23× |
 TRUMYTerumo Corporation | 21.26× |
 PHGKoninklijke Philips N.V. | 27.17× |
Peers are selected by the data provider. Business models and earnings definitions can differ.
Put the numbers in context
What does ZBH’s P/E tell you?
Compare like with like
The median of the 7 positive peer ratios above is 22.23×. Check growth, margins, debt, and earnings quality before interpreting the gap. A faster-growing business may justify a higher multiple.
Check what drives earnings
One-off gains can temporarily lower P/E; unusual charges can raise it. Reported earnings and forward estimates answer different questions. Pair this view with return on equity and liquidity for a fuller picture.
Keep your research connected
Take ZBH into your spreadsheet
Pull historical P/E into Excel or Google Sheets with Wisesheets. Build your own comparisons alongside the rest of your financial model.
Explore WisesheetsQuarterly P/E · latest quarterLQ selects the latest reported quarter. Requires the Wisesheets add-in. See available data
=WISE("ZBH", "PE Ratio", "LQ")Sources & calculation methodology
Current P/E
Share price 110.15 ÷ EPS 8.48 = 12.99×. Data is supplied by Financial Modeling Prep through Wisesheets. Quote feed updated Nov 4, 2026; this is not a real-time trading quote.
History & averages
Annual and quarterly P/E observations are provided separately from the current quote. Averages use the latest 3, 5, or 10 annual observations, excluding missing and nonpositive ratios. Pre-IPO observations are omitted. These are period-end observations, not daily averages.
Data definitions and limitations
The current quote feed does not specify the exact EPS filing-period end or whether EPS is basic or diluted. We do not label it as forward P/E. Peer ratios are explicitly trailing-12-month (TTM) values. Historical observations do not include independently verified price and EPS inputs. Sources may update on different schedules; rounded inputs can produce small calculation differences. Historical comparisons describe past pricing, not an estimate of fair value.
ZBH P/E ratio: common questions
The essentials behind the numbers.
Zimmer Biomet Holdings, Inc.'s current P/E is 12.99× based on the quote data last updated Nov 4, 2026. It represents the share price divided by reported earnings per share. Prices and earnings may refresh on different schedules.
Annual P/E uses earnings for a completed fiscal year. Trailing-12-month (TTM) P/E uses the latest four quarters, while forward P/E uses forecast earnings. These are not interchangeable. This page labels peer ratios as TTM and shows dated annual or quarterly historical observations; it does not show forward estimates.
N/M means not meaningful: the feed has no positive P/E for that observation. Negative or zero earnings should not be ranked as a low positive valuation multiple. N/M observations are excluded from the averages shown above.
Divide the share price by earnings per share (EPS). For example, a share price of 100 and EPS of 5 gives a P/E of 20×. This page uses the price and EPS supplied together in the quote when both are positive.
Price timestamps, EPS definitions, share classes, adjustments, and fiscal periods can differ. A forward P/E also uses forecast earnings rather than reported earnings. Compare the inputs and as-of dates before comparing two displayed ratios.
Not necessarily. The average describes previous market pricing, not fair value. Changes in earnings quality, growth expectations, debt, accounting, and business risk can justify a different multiple today.